Literature DB >> 298436

The diabetic maculopathies.

R A Whitelocke, M Kearns, R K Blach, A M Hamilton.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 298436

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN： 0078-5334


× No keyword cloud information.
  8 in total

1.  Screening for treatable diabetic retinopathy.

Authors:  A J Bron
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-06

2.  Selective retina therapy (SRT) for clinically significant diabetic macular edema.

Authors:  Johann Roider; Shiao Hui Melissa Liew; Carsten Klatt; Hanno Elsner; Erk Poerksen; Jost Hillenkamp; Ralf Brinkmann; Reginald Birngruber
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09       Impact factor: 3.117

Review 3.  Prevention of blindness in diabetic retinopathy.

Authors:  E M Kohner; P J Barry
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

Review 4.  Photocoagulation in the prevention of blindness due to diabetic retinopathy: a review.

Authors:  E M Kohner
Journal:  J R Soc Med       Date:  1984-03       Impact factor: 5.344

5.  Pretreatment of posterior subtenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema.

Authors:  Masahiko Shimura; Toru Nakazawa; Kanako Yasuda; Takashi Shiono; Kohji Nishida
Journal:  Br J Ophthalmol       Date:  2006-10-31       Impact factor: 4.638

6.  Ophthalmic survey of a diabetic clinic: II. Requirements for treatment of retinopathy.

Authors:  R H Grey; A Morris
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

7.  Non-mydriatic Polaroid photography in screening for diabetic retinopathy: evaluation in a clinical setting.

Authors:  D Jones; J Dolben; D R Owens; J P Vora; S Young; F M Creagh
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

8.  Spontaneous evolution and photocoagulation of diabetic cystoid macular edema.

Authors:  P Massin-Korobelnik; A Gaudric; G Coscas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-05       Impact factor: 3.117
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.